Work

A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report

Year: 2019

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz255.010

Authors: S. Kim, N.I. Khushalani, Z. Eroglu, J. Russell, E. Wuthrick, J. Caudell, L. Harrison, M. Aoki, H. Shah, D. Blakaj, J. Markowitz, D.-T. Chen, J. Messina, T. Rose, K. Tsai, A.S. Brohl

Institutions: Moffitt Cancer Center, Janssen (United States), The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2979054249

FWCI: 0.363

Cites:

Cited by: 5

Related to: 10